Investing Ideas
/
U.S. Pharmaceuticals & Biotech High Growth Potential Companies

U.S. Pharmaceuticals & Biotech High Growth Potential Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

183

2 new

Companies with a Future performance score of at least 3, ordered by Future performance score.

183 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ALNY Alnylam Pharmaceuticals	US$237.98	1.6%	23.1%	US$31.0b	US$298.97	PS14.7x	E56.4%	n/a
AXSM Axsome Therapeutics	US$80.05	-7.4%	-6.1%	US$4.0b	US$131.18	PS11.5x	E57.8%	n/a
TGTX TG Therapeutics	US$28.88	-3.9%	83.1%	US$4.1b	US$40.88	PS15.7x	E44.1%	n/a
RCEL AVITA Medical	US$9.14	-31.0%	-37.3%	US$236.2m	US$17.34	PS4x	E51.8%	n/a
TVTX Travere Therapeutics	US$18.09	-4.1%	89.8%	US$1.7b	US$27.40	PS7.7x	E62.5%	n/a
ZVRA Zevra Therapeutics	US$8.11	-5.6%	37.0%	US$455.3m	US$20.63	PS17.7x	E57.8%	n/a
IMGN ImmunoGen	US$31.23	6.6%	617.9%	US$8.4b	US$28.95	PS29.1x	E45.8%	n/a
SGEN Seagen	US$228.74	4.5%	76.5%	US$43.2b	US$228.91	PS18.8x	E71.8%	n/a
ARDX Ardelyx	US$5.07	2.0%	-43.9%	US$1.3b	US$10.44	PS4.8x	E54.7%	n/a
ITCI Intra-Cellular Therapies	US$94.87	13.3%	43.0%	US$8.8b	US$103.21	PS16.4x	E49.0%	n/a
CLNN Clene	US$5.19	-2.8%	-45.9%	US$42.1m	US$45.17	PS98.4x	E59.1%	n/a
BPMC Blueprint Medicines	US$87.43	-1.0%	5.4%	US$5.8b	US$125.58	PS12.8x	E55.4%	n/a
AVDL Avadel Pharmaceuticals	US$7.90	-28.6%	n/a	US$1.0b	US$20.20	PS5.5x	E54.1%	n/a
ISEE IVERIC bio	US$39.95	0.9%	236.3%	US$5.5b	US$40.00	PB11.6x	E59.0%	n/a
ALDX Aldeyra Therapeutics	US$4.94	-9.4%	53.9%	US$304.3m	US$10.00	PB3.5x	E59.9%	n/a
RNXT RenovoRx	US$1.33	-3.6%	20.9%	US$31.7m	US$5.50	PB4.5x	E63.5%	n/a
ABEO Abeona Therapeutics	US$5.55	-7.8%	5.7%	US$259.1m	US$15.90	PB5.3x	E57.8%	n/a
CORT Corcept Therapeutics	US$49.85	-2.0%	114.9%	US$5.4b	US$74.90	PE37.2x	E34.7%	n/a
TNYA Tenaya Therapeutics	US$1.46	-3.9%	-52.3%	US$112.5m	US$18.50	PB1x	E57.8%	n/a
EVOK Evoke Pharma	US$4.20	-9.5%	-53.3%	US$9.1m	US$18.00	PS1x	E124.7%	n/a
SLNO Soleno Therapeutics	US$43.11	-7.2%	3.2%	US$1.9b	US$74.29	PB7x	E58.4%	n/a
CAPR Capricor Therapeutics	US$13.19	-15.5%	198.4%	US$630.2m	US$41.29	PS25.8x	E55.1%	n/a
SPRY ARS Pharmaceuticals	US$11.24	0.4%	90.2%	US$1.1b	US$26.50	PS425.4x	E60.1%	n/a
VNDA Vanda Pharmaceuticals	US$4.60	-5.2%	19.5%	US$271.1m	US$12.17	PS1.4x	E95.9%	n/a

Page 1 of 8